Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 1

Interventions

Specimen Handling 477pembrolizumab 453Magnetic Resonance Spectroscopy 420Carboplatin 332Cyclophosphamide 311Cisplatin 273Biopsy 271Radiotherapy 245Paclitaxel 233Gemcitabine 228Bevacizumab 212Nivolumab 188fludarabine 184venetoclax 179Drug Therapy 170Dexamethasone 158Oxaliplatin 155Blood Specimen Collection 155Injections 153Capecitabine 151Fluorouracil 143Docetaxel 142Radiosurgery 133Standard of Care 132Rituximab 128Pemetrexed 123durvalumab 115atezolizumab 107Leucovorin 107Radiation 106

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Surgery, Computer-Assisted × 1 year × Clear all
NCT03760575 2025-12-04

Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

Abramson Cancer Center at Penn Medicine

Phase 1 Recruiting
20 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡